$VERX

Vertex, Inc. (VERX): Submission of Matters to a Vote of Security Holders

Vertex, Inc. (VERX) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. VERTEX, INC._ June 10, 2026 0001806837 false 0001806837 2026-06-10 2026-06-10 ​ ​ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earlies

Original reporting
Published Jun 11, 2026, 8:35 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 11, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$VERX
Neutral
high confidence
Mentioned
$VERX
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$VERXNeutralLow
01

Why it matters

The disclosure is limited to election and ratification outcomes; it does not introduce new financial information, guidance, or legal/regulatory developments.

02

Market read

Primarily administrative governance disclosure; not a catalyst for earnings, guidance, or risk repricing.

03

What to watch

If there were contested governance items, they are not described here beyond vote counts; no implications for control, litigation, or financial reporting are stated.

Relevance 6/10Novelty 2/10Timing: Filed June 11, 2026 (covers June 10 annual meeting vote results).

Background

SEC 8-K Item 5.07 reports matters submitted to a vote of security holders at Vertex’s annual meeting.

Company-level read

Ticker impact

$VERXNeutralHigh confidence
Context

Vertex filed an 8-K reporting the results of its June 10 annual meeting director elections and auditor ratification votes.

Expected impact

Low probability of sustained price impact; any reaction would be limited to sentiment around governance/controls.

Evidence & confidence

The filing discloses vote tallies for directors and Crowe LLP auditor ratification, with no new strategy, financial guidance, or regulatory outcome.

Market effects

None—no sector-level regulatory or competitive development disclosed.

None—US-listed corporate governance filing only.

None—no cross-border transaction or global regulatory action mentioned.

Counterpoint

Traders could treat auditor ratification as a minor governance signal, but the article provides no change in auditor or audit issues.

Key entities

  • Vertex, Inc.

    Nasdaq-listed company filing the 8-K for annual meeting vote results.

  • Crowe LLP

    Independent auditor for fiscal year ending Dec. 31, 2026, ratified by stockholders.

Related articles

$VERXMedAI 8/10

Vertex Q2 Earnings Call Highlights

Vertex (NASDAQ:VERX) said slower cloud conversion is a timing issue, with customers using mixed cloud and on-prem deployments. Management highlighted strong e-invoicing momentum ahead of France and Germany mandates, expecting e-invoicing to affect ARR in Q3 and more in Q4. Q3 guidance: revenue $208M-$211M, adj. EBITDA $55M-$57M; full-year revenue $825M-$830M and adj. EBITDA $206M-$210M.

$VERXMedAI 8/10

Why is Vertex stock sliding today?

Vertex Pharmaceuticals shares fell 12.8% after its post-close Q2 2026 results. The company reported EPS of $0.20 vs $0.19 consensus and revenue of $203.97M vs $202.29M forecast, but Q3 2026 revenue guidance of $208M-$211M (midpoint below ~$211.69M consensus) and free cash flow of $2.7M disappointed. Morgan Stanley downgraded to Equal Weight and cut its price target to $15 from $19.

$VERXMed

Vertex stock tumbles on cloud growth miss, price target cuts

Vertex Inc. (NASDAQ:VERX) shares dropped 13.2% after its Q2 results missed cloud growth expectations and analysts cut price targets. DA Davidson lowered its target to $12 from $15, citing slower cloud conversions and reduced FY26 cloud growth guidance to 18% from 25%. Other analysts also adjusted targets following guidance and deal-cycle comments.

$VERXMedAI 8/10

Vertex Announces Second Quarter 2026 Financial Results

Vertex, Inc. (NASDAQ: VERX) reported Q2 2026 results for the quarter ended June 30, 2026. Total revenue rose 10.5% to $204.0 million, with software subscription revenue up 10.7% to $174.8 million and cloud revenue up 17.9% to $101.7 million. Adjusted EBITDA increased to $51.0 million. Outlook: Q3 revenue $208.0-$211.0 million and adjusted EBITDA $55.0-$57.0 million; FY 2026 revenue $825.0-$830.0 million and adjusted EBITDA $206.0-$210.0 million.